<SEC-DOCUMENT>0001640334-20-001812-index.html : 20200717 <SEC-HEADER>0001640334-20-001812.hdr.sgml : 20200717 <ACCEPTANCE-DATETIME>20200717163712 ACCESSION NUMBER: 0001640334-20-001812 CONFORMED SUBMISSION TYPE: 424B5 PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20200717 DATE AS OF CHANGE: 20200717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NYMOX PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0001018735 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B5 SEC ACT: 1933 Act SEC FILE NUMBER: 333-237564 FILM NUMBER: 201034119 BUSINESS ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 BUSINESS PHONE: 1-800-936-9669 MAIL ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 </SEC-HEADER> <DOCUMENT> <TYPE>424B5 <SEQUENCE>1 <FILENAME>nymox_424b5.htm <DESCRIPTION>424B5 <TEXT> Document 1 - file: nymox_424b5.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>nymox_424b5img4.jpg <TEXT> Document 2 - file: nymox_424b5img4.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>nymox_424b5img5.jpg <TEXT> Document 3 - file: nymox_424b5img5.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>nymox_424b5img6.jpg <TEXT> Document 4 - file: nymox_424b5img6.jpg
</DOCUMENT> </SEC-DOCUMENT>